Status:
COMPLETED
A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
Lead Sponsor:
GlaxoSmithKline
Conditions:
Social Phobia
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
To compare by neuroimaging techniques the way Social Anxiety patients respond to public speaking before and after a drug administration
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Outpatient with Social Anxiety Disorder
- The subject is healthy
- Willing to restrict alcohol intake
- Capable of giving informed consent
- Exclusion criteria:
- Subjects with depression or any other psychiatric condition
- Subjects positive for HIV or hepatitis
- Subjects taking drugs or other medication
- Pregnant or becoming pregnant during the study
- Subjects who have donated blood
- Subjects who are left-handed
- Subjects with claustrophobia
- Subjects with an electronic device or ferromagnetic metal foreign body
Exclusion
Key Trial Info
Start Date :
January 22 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 7 2009
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00470483
Start Date
January 22 2007
End Date
January 7 2009
Last Update
July 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Barcelona, Spain, E-08003